DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Revlimid (Lenalidomide) - Current Clinical Trials


Revlimid Related Clinical Trials

Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT) [Recruiting]

Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Terminated]

Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas [Active, not recruiting]

Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma [Completed]

Multi-center Trial of Revlimid´┐Ż and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) [Recruiting]

Dasatinib in Combination With Revlimid (and Dexamethasone) [Completed]

A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes [Completed]

Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma [Recruiting]

A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan [Completed]

Evaluation of the Immune Restoration Potential Of Lenalidomide [Not yet recruiting]

Multi-center Trial of Revlimid« and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) [Recruiting]

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) [Active, not recruiting]

Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality [Completed]

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART) [Completed]

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma [Completed]

Registry Study for Individuals With Del 5q Low or Intermediate-1 Risk MDS [Recruiting]

Ipilimumab and Lenalidomide in Advanced Cancer [Recruiting]

Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide) [Not yet recruiting]

Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma [Completed]

Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Completed]

Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma [Active, not recruiting]

Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome [Recruiting]

Dose-Ranging Study of Telintra« Tablets + Revlimid« in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS) [Completed]

CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma [Completed]

Evaluation of Lenalidomide (REVLIMID«) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE) [Completed]

Lenalidomide (Revlimid«, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma [Completed]

A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia [Completed]

Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia [Active, not recruiting]

Maintenance Therapy Using Lenalidomide in Myeloma [Active, not recruiting]

Lenalidomide (Revlimid«) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD) [Terminated]

5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) [Active, not recruiting]

Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL [Terminated]

A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma [Completed]

Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma [Withdrawn]

Lenalidomide Maintenance With High Risk (HR) Acute Myeloid Leukemia (AML) in Remission [Recruiting]

Lenalidomide and Paclitaxel in Prostate Cancer [Active, not recruiting]

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma [Active, not recruiting]

A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma [Completed]

Lenalidomide Plus Rituximab for Indolent Non-Hodgkin's Lymphoma [Active, not recruiting]

Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer [Active, not recruiting]

Lenalidomide and GA101 in Relapsed Indolent Non-Hodgkin's Lymphoma [Recruiting]

Phase II Study of Revlimid«, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma [Completed]

Lenalidomide and Ipilimumab Post Allo or Auto Stem Cell Transplantation (SCT) [Recruiting]

Study of Lenalidomide (Revlimid) in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) Patients [Terminated]

MLN 9708 With Lenalidomide as Maintenance Post Autologous Stem Cell Transplant for Multiple Myeloma Patients [Active, not recruiting]

Study of Lenalidomide to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndromes (MDS) With a Del(5)(q31-33) Abnormality. [Completed]

A Study of Lenalidomide Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Patients With Multiple Myeloma [Completed]


A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer [Terminated]

Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma [Active, not recruiting]

Lenalidomide and High-Dose Melphalan [Completed]

Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma [Enrolling by invitation]

A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma [Not yet recruiting]

Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL) [Completed]

Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients [Recruiting]

Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma [Recruiting]

A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial [Active, not recruiting]

Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I [Terminated]

Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma [Recruiting]

Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL) [Completed]

Study of Elotuzumab With Lenalidomide as Maintenance After Autologous Stem Cell Transplant (ASCT) [Recruiting]

A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Terminated]

Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer [Active, not recruiting]

Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1 [Terminated]

Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma [Completed]

A Phase II Study of CC-5013 in Myelofibrosis [Completed]

Combination of Lenalidomide and Obinutuzumab (GA101) in Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) [Not yet recruiting]

Use of Thalidomide, Lenalidomide, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients [Recruiting]

Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) [Active, not recruiting]

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant [Terminated]

Lenalidomide and R-CHOP in B-cell Lymphoma [Active, not recruiting]

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL) [Recruiting]

Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT) [Recruiting]

Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma [Terminated]

Revlimid in Transfusion Dependent Patients [Active, not recruiting]

Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males [Completed]

A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL). [Terminated]

The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality [Recruiting]

Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age [Active, not recruiting]

Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma [Completed]

Lenalidomide, Thalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma [Active, not recruiting]

Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM) [Completed]

Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes [Completed]

Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma [Recruiting]

Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia [Active, not recruiting]

MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry [Active, not recruiting]

Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma [Completed]

Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL) [Terminated]

Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain [Terminated]

Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma [Recruiting]

Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL [Completed]

Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease [Not yet recruiting]

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas [Recruiting]

A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic Syndromes [Terminated]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017